Cart
0

Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Disease, Gastrointestinal Disorders (GID), Respiratory Diseases, Smoking Cessation, and Others), Product (Software and Devices), and Sales Channel (Business-to-business [B2B] and Business-to-consumers [B2C]): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

Get 20% Free Customization In This Report
LI_182117
Pages: 225
Sep 2018 | 2424 Views
 
Author's : SuraJ Sajeev and Onkar Sumant
Tables: 111
Charts: 35
 

Digital Therapeutic Market Overview:

Digital therapeutic is a digitized health solution, which utilizes digital and online health technologies to treat various medical and psychological conditions. It is a type of apps that helps patients and physicians track health data by modifying patient behavior as well as provide remote monitoring to improve long-term health problems. The global digital therapeutics market was valued at $1,751 million in 2017 and is expected to reach $7,833 million by 2025 at a CAGR of 20.5% during the forecast period.

Factors that drive the growth of the global digital therapeutics market are growing need to control healthcare costs and upsurge in the incidence of chronic diseases. However, lack of awareness toward digital therapeutics acts as a key restraint to the market growth. On the contrary, high growth potential in the developing economies is anticipated to offer significant growth opportunities. 

The global digital therapeutics market is segmented into the application, product, sales channel, and region. The applications covered in the study include diabetes, obesity, cardiovascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. Based on product, the market is classified into software and devices. Depending on sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumer (B2C). Furthermore, the business-to-business (B2B) segment is categorized into employers, healthcare providers, and others. By business-to-consumers, the market is classified into patients and caregivers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Get more information on this report: Request Sample Pages

By application, obesity segment is projected to be one of the most lucrative segments during the forecast period, owing to rise in obese population and increase in the number of cases where treatments is done via smartphone applications for obese population. For instance, according to the WHO, in 2016, more than 1.9 billion adults in the age group of 18 years and above, were overweight, and of these, over 650 million were obese. In addition, several companies have launched a variety of digital therapeutics products. For example, in 2017, Oxil launched an app to tackle increasing cases of obesity among youth. Moreover, Azumio provides fitness buddy mobile app that offers the largest exercise database, which helps reduce obesity. The analysis done by the Noom Inc. (offers mobile health coaching solutions) demonstrated that 78% of users lost weight.

Get more information on this report: Request Sample Pages

Considering the product category, software is projected as one of the dominating segments, owing to the fact that software comprise the base of digital therapeutics and include different health-related apps and platforms. Moreover, software aid in transmitting a patient’s data from wearable devices to physicians via different electronic devices such as mobiles and tablets.Considering the product category, software is projected as one of the dominating segments, owing to the fact that software comprise the base of digital therapeutics and include different health-related apps and platforms. Moreover, software aid in transmitting a patient’s data from wearable devices to physicians via different electronic devices such as mobiles and tablets.

Get more information on this report: Request Sample Pages

Based on region, North America dominated the global market in 2017 and is expected to retain its dominance throughout the forecast period. This is attributed to increase in geriatric population, rise in incidence of chronic diseases, surge in demand for wireless & portable systems, and availability of sophisticated reimbursement structure that aims in reducing expenditure.

The report provides a comprehensive analysis of the key players operating in the global digital therapeutics market. These include Proteus Digital Health, Inc., Omada Health Inc., WellDoc, Inc., 2Morrow, Inc., Livongo Health, Propeller Health, Twine Health, Inc., Canary Health, Inc. Noom Inc., and Medtronic Plc. The other players operating in the value chain are BiogenoQ Inc., Claritas Mindsciences, Jintronix Inc., Virta Health Corp., and Dthera Sciencess.

Key Benefits for Digital Therapeutics Market:

  • The study provides an in-depth analysis along with the current trends and future estimations of the global digital therapeutics market to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided.
  • The quantitative analysis of the industry from 2017 to 2025 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • An extensive analysis of the key segments of the industry is provided to understand the profitability of the various types of products.
  • The key players and their strategies are analyzed to understand the competitive outlook of the market.

Digital Therapeutics Market Key Segments

By Application

  • Diabetes 
  • Obesity
  • Cardio Vascular Diseases (CVD)
  • Central Nervous System (CNS) Disease
  • Gastrointestinal Disorders (GID)
  • Respiratory Diseases
  • Smoking Cessation
  • Others

By Product

  • Software
  • Devices

By Sales Channel

  • Business-to-business (B2B)
    • Employers
    • Healthcare Providers
    • Others
  • Business-to-consumer (B2C)
    • Patients
    • Caregivers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK 
    • Germany 
    • France 
    • Italy 
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan 
    • China
    • Australia 
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil 
    • Turkey
 

Chapter: 1: INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

Chapter: 2: EXECUTIVE SUMMARY

2.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top Winning Strategies
3.2.3. Top Player Positioning, 2017

3.3. Porters five forces analysis
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in adoption of smartphone and tablets coupled with healthcare apps
3.4.1.2. Growth in need to control healthcare costs
3.4.1.3. Rise in incidence of chronic diseases

3.4.2. Restraints

3.4.2.1. Lack of awareness regarding digital therapeutics in developing countries
3.4.2.2. Patient data privacy concerns

3.4.3. Opportunity

3.4.3.1. Emerging markets offer significant growth opportunities

Chapter: 4: DIGITAL THERAPEUTICS MARKET, BY APPLICATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Diabetes

4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country

4.3. Obesity

4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country

4.4. Cardiovascular diseases

4.4.1. Key market trends and growth opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

4.5. Central nervous system (cns) diseases

4.5.1. Key market trends and growth opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country

4.6. Gastrointestinal disorder

4.6.1. Key market trends and growth opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country

4.7. Respiratory diseases

4.7.1. Key market trends and growth opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country

4.8. Smoking cessation

4.8.1. Key market trends and growth opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country

4.9. Others

4.9.1. Key market trends and growth opportunities
4.9.2. Market size and forecast
4.9.3. Market analysis, by country

Chapter: 5: DIGITAL THERAPEUTICS MARKET, BY PRODUCT

5.1. Overview

5.1.1. Market size and forecast

5.2. Software

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Devices

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

Chapter: 6: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL

6.1. Overview

6.1.1. Market size and forecast

6.2. Business-To-Business (b2b)

6.2.1. Market size and forecast, by type
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.2.4. Employer

6.2.4.1. Market size and forecast

6.2.5. Healthcare Providers

6.2.5.1. Market size and forecast

6.2.6. Others

6.2.6.1. Market size and forecast

6.3. Business-to-consumers

6.3.1. Market size and forecast, by type
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.3.4. Patients

6.3.4.1. Market size and forecast

6.3.5. Caregivers

6.3.5.1. Market size and forecast

Chapter: 7: DIGITAL THERAPEUTICS MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North america

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America digital therapeutics market, by country

7.2.2.1. U.S. digital therapeutics market by application
7.2.2.2. U.S digital therapeutics market by product type
7.2.2.3. U.S. digital therapeutics market by sales channel
7.2.2.4. Canada digital therapeutics market by application
7.2.2.5. Canada digital therapeutics market by product type
7.2.2.6. Canada digital therapeutics market by sales channel
7.2.2.7. Mexico digital therapeutics market by application
7.2.2.8. Mexico digital therapeutics market by product type
7.2.2.9. Mexico digital therapeutics market by sales channel

7.2.3. North America digital therapeutics market, by application
7.2.4. North America digital therapeutics market, by product type
7.2.5. North America digital therapeutics market, by sales channel

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe digital therapeutics market, by country

7.3.2.1. UK digital therapeutics market by application
7.3.2.2. UK digital therapeutics market by product type
7.3.2.3. UK digital therapeutics market by sales channel
7.3.2.4. Germany digital therapeutics market by application
7.3.2.5. Germany digital therapeutics market by product type
7.3.2.6. Germany digital therapeutics market by sales channel
7.3.2.7. France digital therapeutics market by application
7.3.2.8. France digital therapeutics market by product type
7.3.2.9. France digital therapeutics market by sales channel
7.3.2.10. Italy digital therapeutics market by application
7.3.2.11. Italy digital therapeutics market by product type
7.3.2.12. Italy digital therapeutics market by sales channel
7.3.2.13. Spain digital therapeutics market by application
7.3.2.14. Spain digital therapeutics market by product type
7.3.2.15. Spain digital therapeutics market by sales channel
7.3.2.16. Rest of Europe digital therapeutics market by application
7.3.2.17. Rest of Europe digital therapeutics market by product type
7.3.2.18. Rest of Europe digital therapeutics market by sales channel

7.3.3. Europe digital therapeutics market, by application
7.3.4. Europe digital therapeutics market, by product type
7.3.5. Europe digital therapeutics market, by sales channel

7.4. Asia-pacific

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific digital therapeutics market, by country

7.4.2.1. Japan digital therapeutics market by application
7.4.2.2. Japan digital therapeutics market by product type
7.4.2.3. Japan digital therapeutics market by sales channel
7.4.2.4. China digital therapeutics market by application
7.4.2.5. China digital therapeutics market by product type
7.4.2.6. China digital therapeutics market by sales channel
7.4.2.7. Australia digital therapeutics market by application
7.4.2.8. Australia digital therapeutics market by product type
7.4.2.9. Australia digital therapeutics market by sales channel
7.4.2.10. India digital therapeutics market by application
7.4.2.11. India digital therapeutics market by product type
7.4.2.12. India digital therapeutics market by sales channel
7.4.2.13. South Korea digital therapeutics market by application
7.4.2.14. South Korea digital therapeutics market by product type
7.4.2.15. South Korea digital therapeutics market by sales channel
7.4.2.16. Rest of Asia-Pacific digital therapeutics market by application
7.4.2.17. Rest of Asia-Pacific digital therapeutics market by product type
7.4.2.18. Rest of Asia-Pacific digital therapeutics market by sales channel

7.4.3. Asia-Pacific digital therapeutics market, by application
7.4.4. Asia-Pacific digital therapeutics market, by product type
7.4.5. Asia-Pacific digital therapeutics market, by sales channel

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA digital therapeutics market, by country

7.5.2.1. Brazil digital therapeutics market by application
7.5.2.2. Brazil digital therapeutics market by product type
7.5.2.3. Brazil digital therapeutics market by sales channel
7.5.2.4. Turkey digital therapeutics market by application
7.5.2.5. Turkey digital therapeutics market by product type
7.5.2.6. Turkey digital therapeutics market by sales channel
7.5.2.7. Saudi Arabia digital therapeutics market by application
7.5.2.8. Saudi Arabia digital therapeutics market by product type
7.5.2.9. Saudi Arabia digital therapeutics market by sales channel
7.5.2.10. South Africa digital therapeutics market by application
7.5.2.11. South Africa digital therapeutics market by product type
7.5.2.12. South Africa digital therapeutics market by sales channel
7.5.2.13. Rest of LAMEA digital therapeutics market by application
7.5.2.14. Rest of LAMEA digital therapeutics market by product type
7.5.2.15. Rest of LAMEA digital therapeutics market by sales channel

7.5.3. LAMEA digital therapeutics market, by application
7.5.4. LAMEA digital therapeutics market, by product type
7.5.5. LAMEA digital therapeutics market, by sales channel

Chapter: 8: COMPANY PROFILES

8.1. PROTEUS DIGITAL HEALTH, INC.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Key strategic moves and developments

8.2. OMADA HEALTH, INC.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Key strategic moves and developments

8.3. WELLDOC, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Key strategic moves and developments

8.4. 2 MORROW INC.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments

8.5. LIVONGO HEALTH

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Key strategic moves and developments

8.6. PROPELLER HEALTH


8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments

8.7. TWINE HEALTH, INC. (FITBIT INC.)

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio

8.8. CANARY HEALTH, INC.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments

8.9. NOOM INC.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Key strategic moves and developments

8.10. MEDTRONIC PLC

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 01. GLOBAL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 02. DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 2017-2025 ($MILLION)
TABLE 03. DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 2017-2025 ($MILLION)
TABLE 04. DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2017-2025 ($MILLION)
TABLE 05. DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY REGION, 2017-2025 ($MILLION)
TABLE 06. SMART PILLS FOR CAPSULE ENDOSCOPY, DRUG DELIVERY, AND PATIENT MONITORING AVAILABLE IN THE MARKET
TABLE 07. DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY REGION, 2017-2025 ($MILLION)
TABLE 08. DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2017-2025 ($MILLION)
TABLE 09. DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 2017-2025 ($MILLION)
TABLE 10. DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY REGION, 2017-2025 ($MILLION)
TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET, BY PRODUCT, 2017-2025 ($MILLION)
TABLE 12. DIGITAL THERAPEUTIC APPLICATIONS AND SOFTWARE PLATFORMS
TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY REGION, 2017-2025 ($MILLION)
TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY REGION, 2017-2025 ($MILLION)
TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 16. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY TYPE, 2017-2025 ($MILLION)
TABLE 17. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY REGION, 2017-2025 ($MILLION)
TABLE 18. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY TYPE, 2017-2025 ($MILLION)
TABLE 19. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY REGION, 2017-2025 ($MILLION)
TABLE 20. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 21. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 22. U.S. DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 23. U.S. DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 24. U.S. DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 25. CANADA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 26. CANADA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 27. CANADA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 28. MEXICO DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 29. MEXICO DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 30. MEXICO DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 31. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 32. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 33. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 34. EUROPE DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 35. UK DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 36. UK DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 37. UK DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 38. GERMANY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 39. GERMANY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 40. GERMANY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 41. FRANCE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 42. FRANCE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 43. FRANCE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 44. ITALY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 45. ITALY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 46. ITALY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 47. SPAIN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 48. SPAIN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 49. SPAIN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 50. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 51. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 52. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 53. EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 54. EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 55. EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 56. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 57. JAPAN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 58. JAPAN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 59. JAPAN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 60. CHINA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 61. CHINA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 62. CHINA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 63. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 64. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 65. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 66. INDIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 67. INDIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 68. INDIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 69. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 70. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 71. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 75. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 76. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 77. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 78. LAMEA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 79. BRAZIL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 80. BRAZIL DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 81. BRAZIL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 82. TURKEY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 83. TURKEY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 84. TURKEY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 85. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 86. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 87. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 88. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 89. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 90. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 91. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 92. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 93. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 94. LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 95. LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 96. LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 97. PROTEUS: COMPANY SNAPSHOT
TABLE 98. PROTEUS: PRODUCT PORTFOLIO
TABLE 99. OMADA: COMPANY SNAPSHOT
TABLE 100. WELLDOC: COMPANY SNAPSHOT
TABLE 101. 2MORROW: COMPANY SNAPSHOT
TABLE 102. LIVONGO: COMPANY SNAPSHOT
TABLE 103. LIVONGO: PRODUCT PORTFOLIO
TABLE 104. PROPELLER: COMPANY SNAPSHOT
TABLE 105. TWINE: COMPANY SNAPSHOT
TABLE 106. CANARY: COMPANY SNAPSHOT
TABLE 107. CANARY: PRODUCT PORTFOLIO
TABLE 108. NOOM: COMPANY SNAPSHOT
TABLE 109. MEDTRONIC: COMPANY SNAPSHOT
TABLE 110. MEDTRONIC: OPERATING SEGMENTS
TABLE 111. MEDTRONIC: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. DIGITAL THERAPEUTICSS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS IN DIGITAL THERAPEUTICSS MARKET, 2017
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2014-2018*
FIGURE 06. TOP PLAYER POSITIONING, 2017
FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08. HIGH BARGAINING POWER OF BUYERS
FIGURE 09. LOW THREAT OF SUBSTITUTION
FIGURE 10. MODERATE THREAT OF NEW ENTRANT
FIGURE 11. MODERATE COMPETITIVE RIVALRY
FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY
FIGURE 13. DIGITAL THERAPEUTICS MARKET BY APPLICATION
FIGURE 14. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DIABETES , BY COUNTRY, 2017 & 2025, 2023 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 22. DIGITAL THERAPEUTICS MARKET, BY PRODUCT
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY COUNTRY, 2017 & 2024 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY COUNTRY, 2017 & 2024 (%)
FIGURE 25. DIGITAL THERAPEUTICS MARKET BY SALES CHANNEL
FIGURE 26. COMPARATIVE ANALYSIS OF BUSINESS-TO-BUSINESS MARKET, BY COUNTRY 2017-2025 ($MILLION)
FIGURE 27. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY EMPLOYER, 2017-2025 ($MILLION)
FIGURE 28. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY HEALTHCARE PROVIDERS, 2017-2025 ($MILLION)
FIGURE 29. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY OTHERS, 2017-2025 ($MILLION)
FIGURE 30. COMPARATIVE ANALYSIS OF BUSINESS-TO-CONSUMERS, BY COUNTRY 2017-2025 ($MILLION)
FIGURE 31. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY PATIENTS, 2017-2025 ($MILLION)
FIGURE 32. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY CAREGIVERS, 2017-2025 ($MILLION)
FIGURE 33. MEDTRONIC, 2015-2017 ($MILLION)
FIGURE 34. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 35. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

 

The global digital therapeutics market is in its nascent stage, and has gained significant attention over the past few years. The market has piqued the interest of healthcare providers, patients, and practioners, owing to several benefits offered by these devices to reduce healthcare expenditure, improve patient & doctor communication, and manage patient health efficiently. Moreover, there have been remarkable advances in the development of novel digital therapeutics applications to provide advanced management options of chronic disease patients and maintain a healthy lifestyle. As the market is saturated and is growing at a steady rate in the developed nations, the Asia-Pacific and LAMEA regions are expected to offer high growth opportunities to the key players in this market.

In addition, rapid penetration of smartphones is projected to increase the usage of digital therapeutics globally. At present, the developing economies have witnessed an increase in adoption of these devices for wellness management, such as fitness, diet & nutrition, and lifestyle & stress, which further boosts the growth of the market.

 

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Digital Therapeutics Market

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4565
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5160
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $6747
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Request Sample

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo